Ben Lacey
MBChB MSc DPhil FFPH
Senior Clinical Research Fellow
Ben Lacey is an epidemiologist and public health physician. He leads the UK Biobank Epidemiology Group, based at the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), University of Oxford. His research interests are in chronic disease epidemiology, health inequalities, and routine health data. He studied medicine at the University of Edinburgh, and received an MSc in Global Health Science and a DPhil in Epidemiology from the University of Oxford. He was elected as a Fellow of the Faculty of Public Health of the Royal Colleges of Physicians in 2012.
Recent publications
-
United Kingdom Biobank (UK Biobank): JACC Focus Seminar 6/8.
Journal article
Caleyachetty R. et al, (2021), J Am Coll Cardiol, 78, 56 - 65
-
Body composition and risk of heart failure: protocol for a systematic review and meta-analysis.
Journal article
Oguntade AS. et al, (2021), Open Heart, 8
-
Long-term trends in population-based hospitalisation rates for myocardial infarction in England: a national database study of 3.5 million admissions, 1968-2016
Journal article
WRIGHT F., (2021), Journal of Epidemiology and Community Health
-
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
Journal article
GBD 2019 Tobacco Collaborators None., (2021), Lancet (London, England), 397, 2337 - 2360
-
Body-mass index, blood pressure, diabetes and cardiovascular mortality in Cuba: prospective study of 146,556 participants.
Journal article
Armas Rojas NB. et al, (2021), BMC Public Health, 21
-
Spatial, temporal, and demographic patterns in prevalence
of chewing tobacco use in 204 countries and territories,
1990–2019: a systematic analysis from the Global Burden of
Disease Study 2019
Journal article
LACEY B., (2021), The Lancet Public Health